Third Military Medical University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1954-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tmmu.edu.cn
Adrenal Artery Ablation Treats Primary Aldosteronism
Phase 3
Completed
- Conditions
- HypertensionPrimary Aldosteronism
- Interventions
- Procedure: Endovascular chemical Ablation of Adrenal Gland
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 66
- Registration Number
- NCT03398785
- Locations
- 🇨🇳
The third hospital affiliated to the Third Military Medical University, Chongqing, Chongqing, China
CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma
Phase 1
- Conditions
- Acute Lymphoblastic LeukemiaBurkitt Lymphoma
- Interventions
- Biological: CD19 CAR T-cellsBiological: CD19 CAR and PD-1 knock out engineered T-cells
- First Posted Date
- 2017-10-02
- Last Posted Date
- 2017-10-02
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 30
- Registration Number
- NCT03298828
PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer
Early Phase 1
- Conditions
- Diabetic Foot Ulcer
- Interventions
- Biological: PRG combined with BMMSCs transplantation
- First Posted Date
- 2017-08-14
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 60
- Registration Number
- NCT03248466
- Locations
- 🇨🇳
Southwest Hospital of the Third Military Medical University, Chongqing, Chongqing, China
🇨🇳Endocrine Department, the First Affiliated Hospital of the Third Military Medical University, Chongqing, Chongqing, China
Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment
Not Applicable
Completed
- Conditions
- ThymomaThymic Tumor
- Interventions
- Radiation: stereotactic body radiation therapy
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2017-03-13
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 32
- Registration Number
- NCT03078699
- Locations
- 🇨🇳
Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China
Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2017-01-23
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 30
- Registration Number
- NCT03029013
- Locations
- 🇨🇳
Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China
Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma
Not Applicable
- Conditions
- Lung Adenocarcinoma, Stage IDiagnoses DiseasesCirculating Tumor CellsTreatment
- Interventions
- Procedure: lobectomyProcedure: segmentecomyDrug: chemotherapy（pemetrexed+CISPLATIN）Procedure: LymphadenectomyOther: CanPatrolTM to detect CTCs
- First Posted Date
- 2016-11-01
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 120
- Registration Number
- NCT02951897
- Locations
- 🇨🇳
Daping hospital, Chongqing, China
Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin
Phase 3
- Conditions
- Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2016-08-23
- Last Posted Date
- 2016-08-24
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT02875457
A Study on the Effects of Interventional Therapy in Patients With Lower Extremity Arterial Occlusive Disease and Its Risk Factors(EILRF)
Not Applicable
- Conditions
- PAD
- Interventions
- Procedure: Percutaneous transluminal angioplasty
- First Posted Date
- 2016-04-26
- Last Posted Date
- 2016-04-26
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 200
- Registration Number
- NCT02752100
- Locations
- 🇨🇳
The third hospital affiliated to the Third Military Medical University, Chongqing, China
SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLC
Phase 2
- Conditions
- Small Cell Lung Cancer
- Interventions
- Radiation: SBRTRadiation: IMRTDrug: EP
- First Posted Date
- 2016-04-14
- Last Posted Date
- 2016-04-14
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 50
- Registration Number
- NCT02738723
- Locations
- 🇨🇳
Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China
The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer
- First Posted Date
- 2016-04-11
- Last Posted Date
- 2016-04-12
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 25
- Registration Number
- NCT02733107
- Locations
- 🇨🇳
Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China